SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 109.19 |
| Enterprise Value ($M) | 1,379.91 |
| Book Value ($M) | 369.98 |
| Book Value / Share | 2.86 |
| Price / Book | 0.30 |
| NCAV ($M) | 323.58 |
| NCAV / Share | 2.50 |
| Price / NCAV | 0.34 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.18 |
| Return on Assets (ROA) | -0.18 |
| Return on Equity (ROE) | -0.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.96 |
| Current Ratio | 10.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 359.66 |
| Assets | 406.06 |
| Liabilities | 36.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.08 |
| Operating Income | -178.35 |
| Net Income | -61.19 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -126.35 |
| Cash from Investing | 20.41 |
| Cash from Financing | 144.41 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Morgan Stanley | 7.80 | -27.79 | |
| 13D/A | Tolerantia, LLC | 38.00 | -0.48 | |
| 13G | BlackRock, Inc. | 5.10 | 0.00 | |
| 13G/A | Suvretta Capital Management, Llc | 10.47 | 179.32 | |
| 13D/A | Control Empresarial de Capitales S.A. de C.V. | 25.30 | 13.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 231,755 | 553,257 | 41.89 | |
| 235,266 | 548,110 | 42.92 | |
| 213,784 | 402,586 | 53.10 | |
| 153,517 | 480,870 | 31.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PMCB – PharmaCyte Biotech, Inc. | PMN – ProMIS Neurosciences, Inc. |
| PRFX – PainReform Ltd. | PRPH – ProPhase Labs, Inc. |
| PRQR – ProQR Therapeutics N.V. |
Financial data and stock pages provided by
Fintel.io